Clinical Trials in Auckland, Auckland

18 recruiting

Showing 115 of 15 trials

Recruiting

Prokinetics and Body Surface Gastric Mapping in Dyspeptic Patients: Baseline and Treatment Effects

GastroparesisFunctional Dyspepsia
University of Auckland, New Zealand125 enrolled3 locationsNCT06854120
Recruiting
Phase 2

SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes

Type 1 Diabetes
SAb Biotherapeutics, Inc.159 enrolled71 locationsNCT07187531
Recruiting
Not Applicable

AAA-SHAPE Pivotal Trial: Abdominal Aortic Aneurysm Sac Healing and Prevention of Expansion

Aortic Aneurysm, Abdominal
Shape Memory Medical, Inc.180 enrolled49 locationsNCT06029660
Recruiting
Phase 3

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Uveal Melanoma
IDEAYA Biosciences520 enrolled94 locationsNCT07015190
Recruiting
Phase 2

A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

Progressive Pulmonary FibrosisInterstitial Lung DiseasePulmonary Fibrosis+7 more
Avalyn Pharma Inc.375 enrolled152 locationsNCT06329401
Recruiting
Phase 3

Long-term Outcomes of Lidocaine Infusions for Post-Operative Pain (LOLIPOP) Trial

Breast CancerMastectomyBreast Cancer Female+1 more
Monash University4,300 enrolled47 locationsNCT05072314
Recruiting
Phase 1

A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B

Chronic Hepatitis B Virus Infection
IntegerBio90 enrolled1 locationNCT07389044
Recruiting
Phase 3

A Study of Subcutaneously Injected Epcoritamab Plus Oral Lenalidomide Tablets Compared to Intravenously (IV) Infused Rituximab Plus IV Infused Gemcitabine and IV Infused Oxaliplatin in Adult Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Genmab360 enrolled177 locationsNCT06508658
Recruiting
Not Applicable

A Platform Trial for Gram Negative Bloodstream Infections

Gram-negative Bacteremia
Sunnybrook Health Sciences Centre2,500 enrolled39 locationsNCT06537609
Recruiting
Phase 1

A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis (AD)
Zai Lab (Shanghai) Co., Ltd.84 enrolled1 locationNCT07235384
Recruiting
Phase 1

A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.

Alopecia Areata
Forte Biosciences, Inc.32 enrolled6 locationsNCT07205159
Recruiting
Phase 1

A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo

Vitiligo
Forte Biosciences, Inc.64 enrolled6 locationsNCT06905873
Recruiting
Phase 2

A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures

Neonatal EncephalopathyNeonatal SeizureSeizure Newborn+1 more
University of California, San Diego133 enrolled5 locationsNCT05610085
Recruiting

SEAL™ME: Saccular Endovascular Aneurysm Lattice System Multicenter Enrollment Global Registry

AneurysmAneurysm, Ruptured
Galaxy Therapeutics INC200 enrolled4 locationsNCT05880680
Recruiting

Predicting Outcomes of GPOEM Using Gastric Electrical Mapping

Gastroparesis
Chris Varghese300 enrolled1 locationNCT06381349